BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25890836)

  • 1. [Sebaceous tumors and Muir-Torre syndrome].
    Bourlond F; Cribier B; Lipsker D; Velter C
    Ann Dermatol Venereol; 2015; 142(6-7):456-9. PubMed ID: 25890836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Facial sebaceous carcinoma: Muir-Torre syndrome].
    Arias-Santiago S; Soriano Hernández MI; Aneiros-Fernández J; Gutiérrez Salmerón MT; Aneiros Cachaza J; Naranjo Sintes R
    Med Clin (Barc); 2010 Jul; 135(6):291. PubMed ID: 19833357
    [No Abstract]   [Full Text] [Related]  

  • 3. Muir-Torre syndrome.
    Narita H; Kanzaki T; Yokota M; Matsuba S
    J Dermatol; 1992 Feb; 19(2):105-8. PubMed ID: 1377720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple asymptomatic papules on the face and thorax.
    Wruhs M; Feldmann R; Breier F; Steiner A
    J Dtsch Dermatol Ges; 2017 Jul; 15(7):749-750. PubMed ID: 28640497
    [No Abstract]   [Full Text] [Related]  

  • 5. [Female patient with Muir-Torre syndrome].
    Negraszus N; Jöhrens K; Bertelmann E
    Ophthalmologe; 2010 Nov; 107(11):1059-62. PubMed ID: 20393721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muir-Torre Syndrome Masquerading as Chalazion.
    Makrygiannis G; Vahdani K; Giasin O
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):422-3. PubMed ID: 26352527
    [No Abstract]   [Full Text] [Related]  

  • 7. Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness.
    Tischkowitz M; Gologan A; Srolovitz H; Khanna M; Foulkes WD
    Br J Cancer; 2006 Jul; 95(2):243-4. PubMed ID: 16786041
    [No Abstract]   [Full Text] [Related]  

  • 8. Sebaceous Neoplasms.
    Flux K
    Surg Pathol Clin; 2017 Jun; 10(2):367-382. PubMed ID: 28477886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite and genetic instability in patients with Muir-Torre syndrome.
    Lorente-Lavirgen AI; Morillo-Andújar M; Zulueta-Dorado T; Conejo-Mir J
    Actas Dermosifiliogr; 2013 Sep; 104(7):643-4. PubMed ID: 23891449
    [No Abstract]   [Full Text] [Related]  

  • 10. Muir-Torre syndrome: clinical features and molecular genetic analysis.
    Esche C; Kruse R; Lamberti C; Friedl W; Propping P; Lehmann P; Ruzicka T
    Br J Dermatol; 1997 Jun; 136(6):913-7. PubMed ID: 9217825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms.
    Schwartz RA; Goldberg DJ; Mahmood F; DeJager RL; Lambert WC; Najem AZ; Cohen PJ
    Dermatologica; 1989; 178(1):23-8. PubMed ID: 2917677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Torre-Muir syndrome. Sebaceous gland tumors indicate colon carcinoma and other internal malignant tumors].
    Karsten U; Christophers E; Sterry W
    Dtsch Med Wochenschr; 1987 Aug; 112(34):1296-301. PubMed ID: 3622267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muir-Torre syndrome.
    Cohen PR; Kohn SR; Davis DA; Kurzrock R
    Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma.
    Kleinerman R; Marino J; Loucas E
    Dermatol Online J; 2012 May; 18(5):3. PubMed ID: 22630573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
    Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
    Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
    Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
    Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muir-Torre syndrome. Diagnostic criteria and review of the literature].
    Hartig C; Stieler W; Stadler R
    Hautarzt; 1995 Feb; 46(2):107-13. PubMed ID: 7706067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sebaceous adenomas in the absence of Muir-Torre syndrome.
    Sia PI; Rajak S; James C; Huilgol S; Selva D
    Can J Ophthalmol; 2016 Oct; 51(5):e152-e153. PubMed ID: 27769341
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
    Landis MN; Davis CL; Bellus GA; Wolverton SE
    J Am Acad Dermatol; 2011 Nov; 65(5):1054-1058.e1. PubMed ID: 21550136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All patients with sebaceous gland neoplasms should be screened for Muir-Torre syndrome.
    Ingram JR; Griffiths AP; Roberts DL
    Clin Exp Dermatol; 2009 Mar; 34(2):264-6. PubMed ID: 19187311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.